Literature DB >> 32297590

Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.

Catherine E Oldenburg1,2,3, Thuy Doan2,1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32297590      PMCID: PMC7253099          DOI: 10.4269/ajtmh.20-0262

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  5 in total

1.  Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.

Authors:  Collins C Iwuji; Joanna Orne-Gliemann; Joseph Larmarange; Eric Balestre; Rodolphe Thiebaut; Frank Tanser; Nonhlanhla Okesola; Thembisa Makowa; Jaco Dreyer; Kobus Herbst; Nuala McGrath; Till Bärnighausen; Sylvie Boyer; Tulio De Oliveira; Claire Rekacewicz; Brigitte Bazin; Marie-Louise Newell; Deenan Pillay; François Dabis
Journal:  Lancet HIV       Date:  2017-11-30       Impact factor: 12.767

2.  A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response.

Authors:  Scott M Berry; Elizabeth A Petzold; Peter Dull; Nathan M Thielman; Coleen K Cunningham; G Ralph Corey; Micah T McClain; David L Hoover; James Russell; J McLeod Griffiss; Christopher W Woods
Journal:  Clin Trials       Date:  2016-01-14       Impact factor: 2.486

3.  The Author's Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR.

Authors:  Jaegyun Lim; Seunghyun Jeon; Hyun Young Shin; Moon Jung Kim; Yu Min Seong; Wang Jun Lee; Kang Won Choe; Yu Min Kang; Baeckseung Lee; Sang Joon Park
Journal:  J Korean Med Sci       Date:  2020-02-24       Impact factor: 2.153

4.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Authors:  Philippe Gautret; Jean-Christophe Lagier; Philippe Parola; Van Thuan Hoang; Line Meddeb; Morgane Mailhe; Barbara Doudier; Johan Courjon; Valérie Giordanengo; Vera Esteves Vieira; Hervé Tissot Dupont; Stéphane Honoré; Philippe Colson; Eric Chabrière; Bernard La Scola; Jean-Marc Rolain; Philippe Brouqui; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-20       Impact factor: 5.283

5.  A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.

Authors:  Bin Cao; Yeming Wang; Danning Wen; Wen Liu; Jingli Wang; Guohui Fan; Lianguo Ruan; Bin Song; Yanping Cai; Ming Wei; Xingwang Li; Jiaan Xia; Nanshan Chen; Jie Xiang; Ting Yu; Tao Bai; Xuelei Xie; Li Zhang; Caihong Li; Ye Yuan; Hua Chen; Huadong Li; Hanping Huang; Shengjing Tu; Fengyun Gong; Ying Liu; Yuan Wei; Chongya Dong; Fei Zhou; Xiaoying Gu; Jiuyang Xu; Zhibo Liu; Yi Zhang; Hui Li; Lianhan Shang; Ke Wang; Kunxia Li; Xia Zhou; Xuan Dong; Zhaohui Qu; Sixia Lu; Xujuan Hu; Shunan Ruan; Shanshan Luo; Jing Wu; Lu Peng; Fang Cheng; Lihong Pan; Jun Zou; Chunmin Jia; Juan Wang; Xia Liu; Shuzhen Wang; Xudong Wu; Qin Ge; Jing He; Haiyan Zhan; Fang Qiu; Li Guo; Chaolin Huang; Thomas Jaki; Frederick G Hayden; Peter W Horby; Dingyu Zhang; Chen Wang
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

  5 in total
  2 in total

Review 1.  Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review.

Authors:  Nitalia Naidoo; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Hypertens Res       Date:  2021-01-20       Impact factor: 5.528

2.  Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study.

Authors:  Fermín Sánchez-Guijo; Mariano García-Arranz; Miriam López-Parra; Pablo Monedero; Carmen Mata-Martínez; Arnoldo Santos; Víctor Sagredo; José-Manuel Álvarez-Avello; José Eugenio Guerrero; César Pérez-Calvo; Miguel-Vicente Sánchez-Hernández; José Luis Del-Pozo; Enrique J Andreu; María-Eugenia Fernández-Santos; Barbara Soria-Juan; Luis M Hernández-Blasco; Etelvina Andreu; José M Sempere; Agustín G Zapata; José M Moraleda; Bernat Soria; Francisco Fernández-Avilés; Damián García-Olmo; Felipe Prósper
Journal:  EClinicalMedicine       Date:  2020-07-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.